Dayal Sujata Tyagi
SEC Form 4 insider trading activity
Dayal Sujata Tyagi has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: May 4, 2026.
On the most recent filing, Dayal Sujata Tyagi is listed as Director at Emergent BioSolutions Inc. Inside the rolling window, Dayal Sujata Tyagi reported no open-market purchases and 2 open-market sales totaling $201K in EBS. The largest disclosed transaction in the window is a sale of 13,761 EBS shares on May 1, 2026, worth $116K.
Companies traded
Other insiders at EBS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$201K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Dayal Sujata Tyagi made?
Dayal Sujata Tyagi has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does Dayal Sujata Tyagi trade?
Dayal Sujata Tyagi has filed SEC Form 4 disclosures for 1 company, including EBS.
When was Dayal Sujata Tyagi's most recent SEC Form 4 filing?
Dayal Sujata Tyagi's most recent SEC Form 4 filing on Tracefour is dated May 4, 2026.
What is Dayal Sujata Tyagi's total buy and sell value in the current window?
Inside the rolling retention window, Dayal Sujata Tyagi bought $0 and sold $201K based on SEC Form 4 filings.
What was Dayal Sujata Tyagi's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 13,761 EBS shares on 2026-05-01, worth $116K, per SEC Form 4 filings.